Longitudinal trends in use and costs of prescription medication in patients with type 1 diabetes: The impact of renal disease

Author： Lithovius Raija   Harjutsalo Valma   Saraheimo Markku   Forsblom Carol   Groop Per-Henrik   on behalf of the FinnDiane Study Group  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.45, Iss.2, 2013-03, pp. : 112-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients

By Suh Dong-Churl   Lee Dong-Hyun   McGuire Michael   Kim Chul-Min  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1623-1633

Informa Healthcare

Access to resources Recommend Favorite

The Impact of Type 2 Diabetes on Mortality in End-Stage Renal Disease Patients Differs between Genders

By  

Nephron Clin Pract, Vol. 112, Iss. 4, 2009-06 ,pp. : c268-c275

Karger

Access to resources Recommend Favorite

Depression, metabolic control, and antidepressant medication in young patients with type 1 diabetes

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 1, 2015-02 ,pp. : 58-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population‐based cohort study

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 19, Iss. 1, 2018-02 ,pp. : 121-128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of medication adherence in patients with type 2 diabetes mellitus

By Curkendall Suellen M.   Thomas Nina   Bell Kelly F.   Juneau Paul L.   Weiss Audrey J.  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1275-1286

Informa Healthcare

Access to resources Recommend Favorite